Translating Research into Biotechs
Translating Research into Biotechs is designed as an educational platform for Cambridge PIs, academic clinicians and early stage founders, led by seasoned company experts. The programme imparts essential knowledge for the formation of biotech companies that come from academic research.
Programme Overview:
- 4 virtual educational sessions, led by leading experts across pharma, investment, law, biotech and venture building
- 1 networking mixer with biotech and venture advisors
- Beginning early 2025 | virtual, bi-Weekly sessions | 5:30pm – 7pm
Session 1: Principles for Founding a Biotech
- Strategic rationale for biotech founding | Optimal company types | Timing for company formation
Session 2: Taking your Research to the Market
- Considering market forces in translating academic work | Intellectual property essentials | Examples of pathways from Bench-To-Bedside
Session 3: Financing and Structuring Biotechs
- Cap tables and term sheets | Non-dilutive (grants) vs dilutive funding (venture capital) | Equity and governance implications | Strategic funding timelines | Building investor relations
Session 4: Considerations of Where You Fit into a Biotech
Leadership decisions (Founder, CEO, CSO, CTO, Chair, Non-Exec Director) | Strategic communication with industry and business development partners | Balancing academia and industry
Final In-Person Session
Invitation to network and gain additional insight from the experts who delivered the program and other biotech leader and investor advisors. Meet the ecosystem!
How to Apply
- If you are a PI / clinical group leader, please register here: https://forms.gle/Tk47duDGeEuSQ2JP6
- If you are an early-stage academic founder, please apply here: https://forms.gle/dpqbKk3hsWQcTyvf8
